Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease

Nature Clinical Practice Neurology

Volumn 4, Issue 4, 2008, Pages 226-232

  Taylor, Kirsten I ^a   Probst, Alphonse ^c   Miserez, André R ^d   Monsch, Andreas U ^b   Tolnay, Markus ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Memory Clinic

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

AGED; ALZHEIMER DISEASE; APATHY; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOPSY; BRAIN ATHEROSCLEROSIS; CASE REPORT; DISEASE COURSE; DISEASE DURATION; FOLLOW UP; GENETIC ANALYSIS; GERIATRIC DEPRESSION SCALE; HEART VENTRICLE HYPERTROPHY; HUMAN; IMAGE ANALYSIS; LABORATORY TEST; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COUNSELING; PATIENT REFERRAL; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASK PERFORMANCE;

AGED; ALZHEIMER DISEASE; BEHAVIORAL SYMPTOMS; COGNITION DISORDERS; FRONTAL LOBE; HUMANS; MALE; PERSONALITY DISORDERS;

EID: 42049090112     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0746     Document Type: Article

References (16)

1. McKhann GM et al. (2001) Clinical and pathological diagnosis of frontotemporal dementia: Report of the work group on frontotemporal dementia and Pick's disease. Arch Neurol 58: 1803-1809
2. Neary D et al. (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51: 1546-1554
3. Johnson JK et al. (1999) Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol 56: 1233-1239
4. Mendez MF and McMurtray A (2006) Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations. Am J Alzheimers Dis Other Demen 21: 281-286
5. Gasparini L et al. (2007) Frontotemporal dementia with tau pathology. Neurodegener Dis 4: 236-253
6. Neary D et al. (2005) Frontotemporal dementia. Lancet Neurol 4: 771-780
7. Snowden JS et al. (2001) Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psych 70: 323-332
8. Gatz M et al. (2006) Roles of genes and environments for explaining Alzheimer disease. Arch Gen Psych 63: 168-174
9. Corder EH et al. (1993) Gene dose of apolipoprotein E ε4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
10. Caine D et al. (2001) Severe anterograde amnesia with extensive hippocampal degeneration in a case of rapidly progressive frontotemporal dementia. Neurocase 7: 57-64
11. Graham AJ et al. (2005) Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain 128: 597-605
12. Knibb JA et al. (2006) Frontotemporal dementia. Curr Opin Neurobiol 19: 565-571
13. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005593. doi:10.1002/14651858.CD005593
14. McShane R et al. Memantine for dementia. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD003154. doi:10.1002/ 14651858.CD003154.pub5
15. Deakin JB et al. (2004) Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: A double-blind randomized controlled trial. Psychopharmacol 172: 400-408
16. Huey ED et al. (2006) A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology 66: 17-22